Riskpilot← Back to searchSign inGet full accessXU CAPITAL AS
ASActiveOrg 994812629Kirkeveien 133D, 1344 HaslumGeneral medical practice activities · NACE 8621Est. 20090 employees
Revenue 2024
NOK 1,8M
-21% vs 2023
EBITDA margin
63.9%
-33% vs 2023
Equity ratio
34.8%
Financial strength
Net profit 2024
NOK -354K
-106% vs 2023
| Revenue | NOK 1,8M | -21% |
| EBITDA | NOK 1,2M | -33% |
| Net profit | NOK -354K | -106% |
| Total assets | NOK 38M | -7% |
| Equity | NOK 13,2M | -3% |
| Employees | 0 | — |
Legal name
XU CAPITAL AS
Org number
994812629
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
26. november 2009
Share capital
NOK 150 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning og drift av fast eiendom.
Address
Kirkeveien 133D, 1344 Haslum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 746 | 957 | 1 273 | 2 312 | 1 833 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 558 | 563 | 717 | 1 752 | 1 171 |
| Depreciation & amort. | −6 | −505 | −695 | −694 | −687 |
| EBIT | 551 | 59 | 22 | 1 058 | 485 |
| Net financials | −539 | 161 | −983 | 4 806 | −839 |
| Profit before tax | 13 | 220 | −961 | 5 864 | −354 |
| Tax | 15 | 2 | −0 | −0 | −0 |
| Net profit | −2 | 218 | −961 | 5 864 | −354 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 27 366 | 26 598 | 37 065 | 40 825 | 37 951 |
| Equity | 8 432 | 8 650 | 7 689 | 13 553 | 13 199 |
| Long-term debt | 18 874 | 16 391 | 24 727 | 26 627 | 22 161 |
| Short-term debt | 61 | 1 558 | 4 649 | 646 | 2 592 |
| Total debt | 18 935 | 17 948 | 29 376 | 27 272 | 24 753 |
EBITDA margin
63.9%
This company
15.8%
Market median
+304% vs market
20202024
Equity ratio
34.8%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
-2.7%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-19.3%
This company
8.1%
Market median
-338% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
1.88×
This company
0.62×
Market median
-203% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TM Chief Executive Officer | Chief Executive Officer | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JX | Board of Directors | 2009 |
| Board of Directors | 2025 | |
| Board of Directors | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
XU CAPITAL AS (this company)
UNIMED EIENDOM ASBoard members of XU CAPITAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tehua Michael Xu | Chief Executive Officer | 0 companies |
| Jin Xu | Board of Directors | 0 companies |
| Wenhui Jiang | Board of Directors | 0 companies |
| Mei Fang Zhang | Board of Directors | 0 companies |